Growth spurt for Wickham Laboratories
Wickham reports that this expansion was initiated due to a marked increase in demand for safety testing under the current regulations and provides an opportunity for expansion of the company’s medical device service offering.
The medical device testing currently available through Wickham Laboratories, and its verified partners, includes a wide range of biocompatibility and general safety tests including ISO 11135-1/11737-2 for sterility testing, ISO 117371-1 for bioburden determination and the ISO 10993 suite of tests for haemocompatibility; cytotoxicity; implantation; sensitisation, skin irritation and pyrogenicity; acute, sub-acute and chronic systemic toxicity.
For medical devices that require varying degrees of biocompatibility and safety testing, Wickham Laboratories says it offers personalised assessments and advice on each device’s individual requirements. The gorup also operates an in vitro R&D division dedicated to the development and validation of a variety of scientifically sound alternative testing methods.